Lifecell Corp.

Innovative biologically based products for the repair and replacement of human tissue.

LifeCell Corporation was formed in 1986 by Dr. Stephen Livesey and colleagues. LifeCell’s first commercialisation was as an equipment manufacturing company to deliver the first preservation technology to the research community. The first clinical product, AlloDerm(R), was brought to market in 1994.

Paul G. Thomas, President & CEO
Bruce Lamb, Ph.D., Senior VP, Development, Regulatory Affairs
Lisa N. Colleran, Senior VP, Commercial Operations
Steven T. Sobieski, VP, Finance and Administration, CFO

Paul G. Thomas, Chairman
Michael E. Cahr
David Fitzgerald
James G. Foster
Michael R. Minogue
Robert P. Roche, Jr.
Martin P. Sutter

One Millennium Way
Branchburg, New Jersey 08876-3876
USA
Phone: +1-908-947-1100

LifeCell markets a broad range of products: AlloDerm®, an acellular tissue matrix for skin grafting for burn and cancer patients as well as for reconstructive surgical procedures; Cymetra®, a version of AlloDerm in particulate form for the correction of soft tissue defects; Repliform®, an acellular tissue matrix for urologic and gynaecologic procedures; Graft Jacket™, an accelular tissue matrix for orthopaedic applications. The company’s ongoing product development programs include the application of its tissue matrix technology to vascular, nerve and orthopaedic tissue repair; the investigation of human tissues as carriers for therapeutics; in addition the company is working on Thrombosol™ to enhance the storage of red blood cells for transfusion.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.